Histone deacetylase 3 (HDAC 3) as emerging drug target in NF-kappa B-mediated inflammation

Niek G. J. Leus, Martijn R. H. Zwinderman, Frank J. Dekker*

*Corresponding author for this work

Research output: Contribution to journalReview articlepeer-review

125 Citations (Scopus)
251 Downloads (Pure)

Fingerprint

Dive into the research topics of 'Histone deacetylase 3 (HDAC 3) as emerging drug target in NF-kappa B-mediated inflammation'. Together they form a unique fingerprint.

Immunology and Microbiology

Keyphrases